Sara Farina
Biographic Data
| ID | 7930527 |
|---|---|
| NAME | Sara Farina |
| GIVEN NAMES | Sara |
| FAMILY NAME | Farina |
| SIGNATURE | FARINA S |
| AFFILIATIONS | Università Cattolica del Sacro Cuore |
| ORCID | 0000-0002-9853-5278 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems
Introduction Personalized prevention is an important component of personalized medicine, tailoring interventions to the biological, behavioral, sociocultural and environmental characteristics of individuals for the prevention of disease onset, progression and recurrence. Despite its potential, personalized preventive interventions (PPI) remain less commonly implemented in clinical practice. This study explored the main barriers to a broader adopt…
Scanning the horizon of personalized prevention research
Introduction: Non-communicable diseases represent a significant burden on global healthcare, necessitating innovative strategies to enhance prevention and management. Personalized prevention, an emerging approach leveraging omics data to tailor interventions, holds promise for improving risk stratification, early diagnosis, and preventive strategies. To gain insights on the latest funding investments in this field, we mapped European Commission (…
Efficacy of polygenic risk scores and digital technologies for Innovative personalized cardiovascular disease PREVention in high-risk adults
Background: Cardiovascular diseases (CVDs) pose a significant global health challenge, necessitating innovative approaches for primary prevention. Personalized prevention, based on genetic risk scores (PRS) and digital technologies, holds promise in revolutionizing CVD preventive strategies. However, the clinical efficacy of these interventions requires further investigation. This study presents the protocol of the INNOPREV randomized controlled …
An IT Platform Supporting Rectal Cancer Tumor Board Activities
Colorectal cancer (RC) is the third most common cancer, with an increasing incidence in recent years. Digital health solutions supporting multidisciplinary tumor boards (MTBs) could improve positive outcomes for RC patients. This paper describes the implementation process of a digital solution within the RC-MTB and its impact analysis in the context of the Fondazione Policlinico 'A. Gemelli' in Italy. Adopting a two-phase methodological approach,…
No prominent works on this page.
An IT Platform Supporting Rectal Cancer Tumor Board Activities
Colorectal cancer (RC) is the third most common cancer, with an increasing incidence in recent years. Digital health solutions supporting multidisciplinary tumor boards (MTBs) could improve positive outcomes for RC patients. This paper describes the implementation process of a digital solution within the RC-MTB and its impact analysis in the context of the Fondazione Policlinico 'A. Gemelli' in Italy. Adopting a two-phase methodological approach,…
Efficacy of polygenic risk scores and digital technologies for Innovative personalized cardiovascular disease PREVention in high-risk adults
Background: Cardiovascular diseases (CVDs) pose a significant global health challenge, necessitating innovative approaches for primary prevention. Personalized prevention, based on genetic risk scores (PRS) and digital technologies, holds promise in revolutionizing CVD preventive strategies. However, the clinical efficacy of these interventions requires further investigation. This study presents the protocol of the INNOPREV randomized controlled …
Scanning the horizon of personalized prevention research
Introduction: Non-communicable diseases represent a significant burden on global healthcare, necessitating innovative strategies to enhance prevention and management. Personalized prevention, an emerging approach leveraging omics data to tailor interventions, holds promise for improving risk stratification, early diagnosis, and preventive strategies. To gain insights on the latest funding investments in this field, we mapped European Commission (…
A multi-stakeholder perspective on barriers to the adoption of personalized prevention in European healthcare systems
Introduction Personalized prevention is an important component of personalized medicine, tailoring interventions to the biological, behavioral, sociocultural and environmental characteristics of individuals for the prevention of disease onset, progression and recurrence. Despite its potential, personalized preventive interventions (PPI) remain less commonly implemented in clinical practice. This study explored the main barriers to a broader adopt…
Health care (3 works) · Medicine (3 works) · Nutrition, Genetics, and Disease (3 works) · BRCA gene mutations in cancer (2 works) · Computer Science (2 works) · Health professionals (2 works) · Internal Medicine (2 works) · Psychological intervention (2 works) · Alternative medicine (1 work) · Bioinformatics (1 work)